Continuous Renal Replacement Therapy Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets and Tub

Continuous Renal Replacement Therapy Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets and Tubes, and CRRT Systems), Modality [Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), and Slow Continuous Ultrafiltration (SCUF)], and End User (Hospitals, Ambulatory Care Centers, Homecare, and Others)

According to our latest study on Continuous Renal Replacement Therapy Market Forecast to 2030 – Global Analysis –Product, Modality, End User, and Geography, the market was valued at US$ 1.42 billion in 2022 and is expected to reach US$ 2.75 billion by 2030; it is estimated to register a CAGR of 8.7% from 2022 to 2030.

Continuous renal replacement therapy (CRRT) has become the recommended dialysis option for children admitted to ICUs for AKI treatments. The indications for renal replacement in the pediatric population have changed due to a wide range of pediatric diseases. The range of CRRT applications has expanded with its proven effectiveness in treating nonrenal indications, primarily, in critically ill newborns. For instance, the Carpediem system by Medtronic offers a dedicated extracorporeal CRRT for low-weight patients; as per the company’s claims, the device responds effectively to the needs of the most fragile patients. Moreover, PRISMASOL and PHOXILLUM solutions by Baxter are indicated as a replacement solution in CRRT to replace plasma volume removed by ultrafiltration as well as to correct electrolyte and acid-base imbalances in pediatric and adult patients. Thus, the increased demand for pediatric CRRT devices benefits the continuous renal replacement therapy market growth.

By Product, Continuous Renal Replacement Therapy Market-Based Insights

Based on product, the continuous renal replacement therapy market is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022. The hemofilters segment is likely to register the highest CAGR in the market during 2022–2030. The hemofilters are composed of a hollow-fiber membrane that controls the volume of fluids and solutes evacuated. By eliminating solutes (waste products, electrolytes, and other molecules), CRRT hemofilter membranes imitate some of the activities of the kidney. Moreover, they may help restore fluid status and acid-base balance through their function.

By End User, Continuous Renal Replacement Therapy Market-Based Insights

The continuous renal replacement therapy market, by end-user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospital segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022–2030. In 2023, the US had 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals, according to the American Hospital Association. Further, the growing elderly population and the notable rise in hospital admissions for AKI are the key factors that propel the demand for CRRT systems in hospitals.

National Institutes of Health, company’s investor reports, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the continuous renal replacement therapy market.